• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.

出版信息

BMJ. 2018 Oct 18;363:k4413. doi: 10.1136/bmj.k4413.

DOI:10.1136/bmj.k4413
PMID:30337336
Abstract
摘要

相似文献

1
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.真实世界中直接口服抗凝剂与华法林的风险和获益比较：初级保健队列研究
BMJ. 2018 Oct 18;363:k4413. doi: 10.1136/bmj.k4413.
2
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.直接口服抗凝剂与华法林在真实世界环境中的风险和获益：初级保健中的队列研究。
BMJ. 2018 Jul 4;362:k2505. doi: 10.1136/bmj.k2505.
3
Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.口服抗凝剂治疗非瓣膜性心房颤动患者的大出血风险：真实世界观察性研究的系统评价
Curr Med Res Opin. 2017 Sep;33(9):1583-1594. doi: 10.1080/03007995.2017.1347090. Epub 2017 Jul 6.
4
Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.直接口服抗凝剂与华法林治疗静脉血栓栓塞症患者的住院时间：一项真实世界的单中心研究。
J Thromb Thrombolysis. 2018 Jul;46(1):16-21. doi: 10.1007/s11239-018-1661-y.
5
Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol.真实世界实践中口服抗凝剂治疗心房颤动的比较有效性和安全性：一项基于人群的队列研究方案
BMJ Open. 2016 Nov 24;6(11):e013263. doi: 10.1136/bmjopen-2016-013263.
6
Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States.在美国，新型口服抗凝药与华法林用于静脉血栓栓塞时的真实世界医疗费用避免情况。
Clin Appl Thromb Hemost. 2016 Jan;22(1):5-11. doi: 10.1177/1076029615585991. Epub 2015 May 19.
7
Real-World Impact of Setting a Narrow International Normalized Ratio Target Range in the Management of Older Adult Patients on Warfarin.设定狭窄国际标准化比值目标范围对华法林治疗老年患者的实际影响
Clin Appl Thromb Hemost. 2016 Sep;22(6):528-34. doi: 10.1177/1076029615598220. Epub 2015 Aug 2.
8
Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.比较直接口服抗凝剂与华法林用于心房颤动、静脉血栓栓塞和机械心脏瓣膜的情况。
Consult Pharm. 2015 Nov;30(11):644-56. doi: 10.4140/TCP.n.2015.644.
9
Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.开发一种共享决策工具，以协助患者和临床医生就心房颤动的口服抗凝治疗做出决策。
Curr Med Res Opin. 2015 Dec;31(12):2261-72. doi: 10.1185/03007995.2015.1096767. Epub 2015 Oct 22.
10
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.竞争风险对估计目前未服用抗凝剂的房颤患者华法林预期获益的影响：房颤抗凝与危险因素研究
J Am Geriatr Soc. 2017 Jan;65(1):35-41. doi: 10.1111/jgs.14516. Epub 2016 Nov 12.

引用本文的文献

1
Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients.抗凝和抗血小板药物对创伤患者手术率和死亡率的影响。
Sci Rep. 2021 Jul 26;11(1):15172. doi: 10.1038/s41598-021-94675-7.